- Home
- CGEM vs CNNE Comparison
CGEM vs CNNE Comparison
Compare CGEM & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGEM | CNNE |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 780.4M | 822.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CGEM | CNNE |
|---|---|---|
| Price | $12.10 | $13.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $28.80 | $22.25 |
| AVG Volume (30 Days) | ★ 676.1K | 474.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.68 | $12.98 |
| 52 Week High | $13.43 | $21.96 |
Technical Indicators
Market Signals| Indicator | CGEM | CNNE |
|---|---|---|
| Relative Strength Index (RSI) | 53.63 | 25.15 |
| Support Level | $11.40 | $14.05 |
| Resistance Level | $12.55 | $14.45 |
| Average True Range (ATR) | 0.87 | 0.45 |
| MACD | -0.11 | -0.11 |
| Stochastic Oscillator | 32.85 | 6.40 |
Price Performance
Historical ComparisonAbout CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.